HDAC9 and cancer: Since Nrf2 is a transcription factor responsible for the upregulation of cytoprotective factors [83,84,85], the activation of the Nrf2 pathway by HDAC inhibitors could even result in unwanted prosurvival effects in cancer cells [86].